Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

NCT05179057 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
57
Enrollment
INDUSTRY
Sponsor class

Stopped Study discontinued as DSMB determined it was futile. No safety concerns were noted.

Conditions

Interventions

Sponsor

AlloVir